AJAP1 | Adherens junctions associated protein 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP1 | A kinase (PRKA) anchor protein 1 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AL021546.6 | Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial {ECO:0000313|Ensembl:ENSP00000229384} | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALCAM | Activated leukocyte cell adhesion molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
ALDH3A2 | Aldehyde dehydrogenase 3 family, member A2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALDH3B2 | Aldehyde dehydrogenase 3 family, member B2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALG1 | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALG10 | ALG10, alpha-1,2-glucosyltransferase | Enzymes Predicted membrane proteins
| | | | | Mixed |
ALG10B | ALG10B, alpha-1,2-glucosyltransferase | Enzymes Predicted membrane proteins
| | | | | Mixed |
ALG11 | ALG11, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALG12 | ALG12, alpha-1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG2 | ALG2, alpha-1,3/1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALG3 | ALG3, alpha-1,3- mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG6 | ALG6, alpha-1,3-glucosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG8 | ALG8, alpha-1,3-glucosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG9 | ALG9, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALG9 | ALG9, alpha-1,2-mannosyltransferase | Predicted membrane proteins
| | | | | Tissue enhanced |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALOX5AP | Arachidonate 5-lipoxygenase-activating protein | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ALPK1 | Alpha-kinase 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ALS2CL | ALS2 C-terminal like | Predicted intracellular proteins
| | | | | Tissue enhanced |
AMACR | Alpha-methylacyl-CoA racemase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
AMDHD1 | Amidohydrolase domain containing 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
AMFR | Autocrine motility factor receptor, E3 ubiquitin protein ligase | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AMICA1 | Adhesion molecule, interacts with CXADR antigen 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMIGO1 | Adhesion molecule with Ig-like domain 1 | Predicted membrane proteins
| | | | | Mixed |
AMIGO2 | Adhesion molecule with Ig-like domain 2 | Predicted membrane proteins
| | | | | Mixed |
AMIGO3 | Adhesion molecule with Ig-like domain 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
AMN | Amnion associated transmembrane protein | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ANAPC1 | Anaphase promoting complex subunit 1 | Cancer-related genes Predicted membrane proteins
| | | | | Expressed in all |
ANKAR | Ankyrin and armadillo repeat containing | Predicted intracellular proteins
| | | | | Tissue enriched |
ANKH | ANKH inorganic pyrophosphate transport regulator | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ANKLE1 | Ankyrin repeat and LEM domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ANKLE2 | Ankyrin repeat and LEM domain containing 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ANKRD22 | Ankyrin repeat domain 22 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD29 | Ankyrin repeat domain 29 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ANKRD32 | Ankyrin repeat domain 32 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ANKRD42 | Ankyrin repeat domain 42 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD46 | Ankyrin repeat domain 46 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ANO10 | Anoctamin 10 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ANO2 | Anoctamin 2, calcium activated chloride channel | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO3 | Anoctamin 3 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ANO4 | Anoctamin 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ANO5 | Anoctamin 5 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ANO6 | Anoctamin 6 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ANO7 | Anoctamin 7 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANO8 | Anoctamin 8 | Predicted membrane proteins
| | | | | Expressed in all |